Company
United StatesPublic company, NASDAQ: AMRXAmneal Pharmaceuticals, LLC (NASDAQ: AMRX), Bridgewater, NJ – FDA Inspections
Inspection records and compliance data for Amneal Pharmaceuticals, LLC in Bridgewater, NJ. 1 FDA inspection on record, last inspected December 01, 2023. Publicly traded as NASDAQ: AMRX.
Company Profile
This profile covers Amneal Pharmaceuticals, LLC based in Bridgewater, NJ, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected December 1, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 1, 2023 | Not classified | Medical Devices & Rad Health | 1224318 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Curio Digital Therapeutics Inc.
Montclair Radiology
Ami - Atlanticare Partners In Imaging
Hudson River Radiology Center
Garden State Diagnostic Imaging
Valley Health System Montvale Campus Diagnostic Imaging
Hackensack Radiology - Hoboken
Atlantic Medical Imaging - Festival @ Hamilton
Women's Center at Rancocas Hospital
Millburn Medical Imaging, P.A.
Company Information
Name
Amneal Pharmaceuticals, LLC
Stock ticker
AMRX
Exchange
NASDAQ
Share price
$19.46
Market cap
$6.8B
Price as of
November 6, 2026
FEI Number
3012625281
Address
400 Crossing Blvd Fl 3, Bridgewater, NJ 08807-2863, United States
Country
United States
ID: 679d7938-4ed2-4284-923d-31dab9d076d9